title: Association between virological response and decline in hemoglobin concentration during pegylated interferon and ribavirin therapy in HCV genotype 1: another story.
authors.forename: Chia-Yen
authors.initials: CY
authors.lastname: Dai
authors.forename: Chung-Feng
authors.initials: CF
authors.lastname: Huang
authors.forename: Jee-Fu
authors.initials: JF
authors.lastname: Huang
authors.forename: Wan-Long
authors.initials: WL
authors.lastname: Chuang
authors.forename: Ming-Lung
authors.initials: ML
authors.lastname: Yu
mesh_terms: D000740:Anemia / Q000139:chemically induced*; D000998:Antiviral Agents / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D005838:Genotype; D006454:Hemoglobins / Q000032:analysis*; D016174:Hepacivirus / Q000235:genetics*; D019698:Hepatitis C, Chronic / Q000097:blood / Q000188:drug therapy* / Q000821:virology; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects*; D011092:Polyethylene Glycols / Q000009:adverse effects*; D011994:Recombinant Proteins; D012254:Ribavirin / Q000009:adverse effects*
chemical_list: D000998:Antiviral Agents; D006454:Hemoglobins; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D012254:Ribavirin; C100416:peginterferon alfa-2a